Engineered natural killer cells expressing chimeric CD64

Project: Research project

Project Details

Description

Engineered natural killer cells expressing chimeric CD64 as a cancer immunotherapy
StatusFinished
Effective start/end date7/1/186/30/19

Funding

  • MN OVARIAN CANCER ALLIANCE

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.